Cargando…
Mucositis and Infection in Hematology Patients
Survival in patients with hematological malignancies has improved over the years, both due to major developments in anticancer treatment, as well as in supportive care. Nevertheless, important and debilitating complications of intensive treatment regimens still frequently occur, including mucositis,...
Autores principales: | Blijlevens, Nicole M. A., de Mooij, Charlotte E. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253974/ https://www.ncbi.nlm.nih.gov/pubmed/37298545 http://dx.doi.org/10.3390/ijms24119592 |
Ejemplares similares
-
The EHA Research Roadmap: Infections in Hematology
por: Cordonnier, Catherine, et al.
Publicado: (2021) -
Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
por: Einsele, Hermann, et al.
Publicado: (2020) -
Genomic Stratification of Hematological Malignancies
por: Robbe, Pauline, et al.
Publicado: (2023) -
Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)—study protocol for a multicenter randomized double-blind placebo-controlled trial
por: de Mooij, Charlotte E. M., et al.
Publicado: (2020) -
Biologicals and Biosimilars in Hematology: The Case of Rituximab
por: Vulto, Arnold G.
Publicado: (2019)